Gynecological Infection

• FDA approval · 2021-04-16
  FDA Approved: AZACTAM — Supplemental Application (E.R. Squibb & Sons, L.L.C.)

  FDA approved a supplemental application for AZACTAM (aztreonam) from E.R. Squibb & Sons, L.L.C. The approval updates the product labeling fo…

• CLINICAL_TRIALS trial_result · 2016-01-14
  Clinical Trial Update: Immune Modulation by Misoprostol [EARLY_Phase 1]

  An early-phase 1 trial evaluates how misoprostol modulates the immune response in gynecological infections. The study has completed.

• FDA approval · 2011-01-27
  FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

  The FDA approved a supplemental application for amoxicillin and clavulanate potassium (Hikma Pharmaceuticals USA Inc.), updating the product…